Psyence Biomedical LTD. (PBM) — SEC Filings
Latest SEC filings for Psyence Biomedical LTD.. Recent 6-K filing on Apr 23, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Psyence Biomedical LTD. on SEC EDGAR
Overview
Psyence Biomedical LTD. (PBM) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 23, 2026: Psyence Biomedical Ltd. filed a Form 6-K on April 23, 2026, reporting a press release titled "PSYENCE BIOMED INITIATES PATIENT DO". The filing includes the press release as Exhibit 99.1 and the complete submission text file.
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Psyence Biomedical LTD. is neutral.
Filing Type Overview
Psyence Biomedical LTD. (PBM) has filed 2 6-K with the SEC between Apr 2026.
Recent Filings (2)
-
Psyence Biomed Initiates Patient Dosing
— 6-K · Apr 23, 2026 Risk: medium
Psyence Biomedical Ltd. filed a Form 6-K on April 23, 2026, reporting a press release titled "PSYENCE BIOMED INITIATES PATIENT DO". The filing includes the pres - 6-K Filing — 6-K · Apr 20, 2026
Risk Profile
Risk Assessment: Of PBM's 1 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 0 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Top Tags
clinical-trial (1) · press-release (1) · biotech (1)
Frequently Asked Questions
What are the latest SEC filings for Psyence Biomedical LTD. (PBM)?
Psyence Biomedical LTD. has 2 recent SEC filings from Apr 2026, including 2 6-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PBM filings?
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.
Where can I find Psyence Biomedical LTD. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Psyence Biomedical LTD. (PBM) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Psyence Biomedical LTD.?
Financial highlights for Psyence Biomedical LTD. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for PBM?
Investment thesis data for PBM will be available once enriched filings are processed.
Who are the key executives at Psyence Biomedical LTD.?
Executive information for Psyence Biomedical LTD. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Psyence Biomedical LTD. stock?
Of PBM's 1 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Psyence Biomedical LTD.?
Forward guidance and predictions for Psyence Biomedical LTD. are extracted from SEC filings as they are enriched.